Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study∗
Elena Butz(University of Freiburg), Peggy Sekula(University of Freiburg), Inga Steinbrenner(University of Freiburg), Charlotte Behning(University Hospital Bonn), Helena Hansmann, Elke Schaeffner, Ulla T. Schultheiss(University of Freiburg), Peter J. Oefner(University of Regensburg), Anna Köttgen(Johns Hopkins University), Wolfram Gronwald(University of Regensburg), Kai-Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Harald Binder(Zimmer Biomet (Netherlands))
Cited by 0
Related Papers
Combined chemical shift changes and amino acid specific chemical shift mapping of protein–protein interactions
|Journal of Biomolecular NMR|2007|236
Advances in amino acid analysis
|Analytical and Bioanalytical Chemistry|2008|235
State-of-the art data normalization methods improve NMR-based metabolomic analysis
|Metabolomics|2011|224
BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2018|216
A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population
|Journal of the American Society of Nephrology|2015|206